thiorphan has been researched along with enalaprilat anhydrous in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 9 (81.82) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, MJ; Elliott, RL; Marks, N; Portoghese, PS | 1 |
| Berry, CJ; Fink, CA; Ghai, RD; Qiao, Y; Sakane, Y; Trapani, AJ | 1 |
| Crippen, GM | 1 |
| Opgenorth, TJ; Pollock, DM | 1 |
| Autry, WL; Barbaz, BS; Norman, JA | 1 |
| Fournié-Zaluski, MC; Lévy, B; Michel, JB; Pham, I; Poitevin, P; Roques, BP | 1 |
| el Amrani, AI; Fournié-Zaluski, MC; Gonzalez, W; Laboulandine, I; Michel, JB; Pham, I; Philippe, M; Roques, BP | 1 |
| Doucet, J; Fournie-Zaluski, MC; Gonzalez, W; Michel, JB; Pham, I; Roques, BP | 1 |
| Adam, A; Blais, C; Drapeau, G; Gervais, N; Lamontagne, D; Raymond, P; Venneman, I | 1 |
| Adam, A; Blais, C; Dumoulin, MJ; Lamontagne, D | 1 |
| Bernstein, R; Hintze, TH; Nasjletti, A; Recchia, FA; Xu, X; Zhang, X | 1 |
11 other study(ies) available for thiorphan and enalaprilat anhydrous
| Article | Year |
|---|---|
Synthesis and biological evaluation of phosphonamidate peptide inhibitors of enkephalinase and angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Chemical Phenomena; Chemistry; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalins; Humans; Kidney; Neprilysin; Organophosphorus Compounds; Protease Inhibitors; Rats; Structure-Activity Relationship | 1985 |
New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Captopril; Dipeptides; Magnetic Resonance Spectroscopy; Male; Neprilysin; Peptidyl-Dipeptidase A; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfhydryl Compounds; Thiorphan; Tryptophan | 1995 |
Validation of EGSITE2, a mixed integer program for deducing objective site models for experimental binding data.
Topics: Algorithms; Animals; Binding Sites; Computer Simulation; Folic Acid Antagonists; Models, Molecular; Peptidyl-Dipeptidase A; Protein Binding; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Steroids; Testosterone; Tetrahydrofolate Dehydrogenase; Transcortin | 1997 |
Evidence for metalloprotease involvement in the in vivo effects of big endothelin 1.
Topics: Animals; Diuresis; Enalaprilat; Endothelin-1; Endothelins; Glomerular Filtration Rate; Glycopeptides; Hemodynamics; Infusions, Intravenous; Kidney; Male; Metalloendopeptidases; Natriuresis; Potassium; Protein Precursors; Rats; Rats, Inbred Strains; Renal Circulation; Thiorphan | 1991 |
Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain.
Topics: Analgesics; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Captopril; Enalapril; Enalaprilat; Enkephalin, Methionine; Hydrolysis; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Peptidyl-Dipeptidase A; Synaptic Membranes; Thiorphan; Tiopronin | 1985 |
Acute hemodynamic effects of combined inhibition of neutral endopeptidase and angiotensin converting enzyme in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Drug Therapy, Combination; Enalaprilat; Heart Rate; Hemodynamics; Hypertension; Kinetics; Neprilysin; Rats; Rats, Inbred SHR; Thiorphan; Time Factors | 1995 |
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Desoxycorticosterone; Diuresis; Enalaprilat; Hypertension, Renovascular; Kidney; Male; Natriuresis; Neprilysin; Protease Inhibitors; Rats; Rats, Inbred SHR; Rats, Wistar; Sodium Chloride; Sulfhydryl Compounds; Thiorphan | 1993 |
Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cyclic GMP; Enalaprilat; Hypertension; Kidney; Male; Neprilysin; Rats; Rats, Wistar; Thiorphan | 1996 |
Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: an interspecies study.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies; Bradykinin; Cross Reactions; Dogs; Enalaprilat; Humans; Kinetics; Losartan; Myocardium; Peptidyl-Dipeptidase A; Protease Inhibitors; Rabbits; Rats; Species Specificity; Substrate Specificity; Thiorphan | 1997 |
Metabolism of bradykinin by the rat coronary vascular bed.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Chromatography, High Pressure Liquid; Coronary Circulation; Coronary Vessels; Enalaprilat; Hemodynamics; Immunoenzyme Techniques; In Vitro Techniques; Male; Neprilysin; Perfusion; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Thiorphan; Time Factors | 1998 |
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Coronary Vessels; Cysteine Proteinase Inhibitors; Dogs; Enalaprilat; Glycopeptides; Heart Failure; Kininogens; Kinins; Nitric Oxide; Protease Inhibitors; Ramipril; Receptor, Bradykinin B2; Thiorphan; Vasodilator Agents | 1999 |